NRNP 6675 MIDTERM EXAM
NRNP 6675 MIDTERM EXAM
STUDY GUIDE. GRADED A+.
QUESTIONS AND 100%
VERIFIED ANSWERS. LATEST
UPDATE
1. Which of the following are risk factors for neuroleptic malignant
syndrome? Select all that applyAge
Rapid dose escalation
Parental route of administration
Higher potency typical antipsychotics
2. Antipsychotic medications provide D2 blockade in the mesocortical
,NRNP 6675 MIDTERM EXAM
pathway causing which of thefollowing effects?
Reduces negative symptoms
Increases extra pyramidal symptoms
(EPS)Causes
prolactinemia Reduces
positive symptoms
3. Phencyclidine (PCP) and Ketamine exert their unique behavioral effects
by blocking which of thefollowing receptors?
GABA
type
receptor
s
,NRNP 6675 MIDTERM EXAM
Serotoni
n
receptor
s
Dopamine receptors
NMDA type receptors
4.The diagnosis used to describe a syndrome characterized by specific signs
and symptoms resultingfrom recent ingestion or exposure to a substance is
known as which of the following?
Substance
, NRNP 6675 MIDTERM EXAM
intoxicati
on
Substance
withdraw
al
Substance use
disorderAny of
the above
Abnormal involuntary movements in a rhythmic pattern affecting face,
5.
mouth, tongue, jaw is knownas which of the following?
Akathi
si a
Dyston
ia
Tardive dyskinesia
Extrapyramidal
side effects
NRNP 6675 MIDTERM EXAM
STUDY GUIDE. GRADED A+.
QUESTIONS AND 100%
VERIFIED ANSWERS. LATEST
UPDATE
1. Which of the following are risk factors for neuroleptic malignant
syndrome? Select all that applyAge
Rapid dose escalation
Parental route of administration
Higher potency typical antipsychotics
2. Antipsychotic medications provide D2 blockade in the mesocortical
,NRNP 6675 MIDTERM EXAM
pathway causing which of thefollowing effects?
Reduces negative symptoms
Increases extra pyramidal symptoms
(EPS)Causes
prolactinemia Reduces
positive symptoms
3. Phencyclidine (PCP) and Ketamine exert their unique behavioral effects
by blocking which of thefollowing receptors?
GABA
type
receptor
s
,NRNP 6675 MIDTERM EXAM
Serotoni
n
receptor
s
Dopamine receptors
NMDA type receptors
4.The diagnosis used to describe a syndrome characterized by specific signs
and symptoms resultingfrom recent ingestion or exposure to a substance is
known as which of the following?
Substance
, NRNP 6675 MIDTERM EXAM
intoxicati
on
Substance
withdraw
al
Substance use
disorderAny of
the above
Abnormal involuntary movements in a rhythmic pattern affecting face,
5.
mouth, tongue, jaw is knownas which of the following?
Akathi
si a
Dyston
ia
Tardive dyskinesia
Extrapyramidal
side effects
